World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
68
Citations
23300
World Ranking
2550
National Ranking
1224

Ronald T. Mitsuyasu publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ronald T. Mitsuyasu sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 235 publications — 46th percentile

46% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Ronald T. Mitsuyasu D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ronald T. Mitsuyasu sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 68 D-Index — 49th percentile

49% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Ronald T. Mitsuyasu is affiliated with the University of California, Los Angeles in the United States. Their research primarily focuses on the field of Medicine, with significant contributions to subfields such as Oncology, Pathology and Forensic Medicine, Surgery, Infectious Diseases, and Genetics.

The scientist's work covers several main topics, including:

  • Lymphoma Diagnosis and Treatment
  • Viral-associated cancers and disorders
  • Chronic Lymphocytic Leukemia Research
  • HIV Research and Treatment
  • Colorectal and Anal Carcinomas
  • HIV/AIDS drug development and treatment
  • CNS Lymphoma Diagnosis and Treatment

Ronald T. Mitsuyasu has published extensively, with notable presence in frequent publication venues such as:

  • Clinical Cancer Research
  • Blood
  • Scientific Reports
  • UNC Libraries
  • New England Journal of Medicine

Selected recent papers authored or coauthored by Ronald T. Mitsuyasu include:

  • "Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer" (2022), published in New England Journal of Medicine
  • "Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma" (2020), published in Journal of Clinical Oncology
  • "HIV-1 remission and possible cure in a woman after haplo-cord blood transplant" (2023), published in Cell
  • "Genetic subgroups inform on pathobiology in adult and pediatric Burkitt lymphoma" (2022), published in Blood
  • "Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial)" (2020), published in Blood

The scientist collaborates frequently with other researchers, including:

  • Richard F. Ambinder
  • Joseph A. Sparano
  • Jeannette Y. Lee
  • David M. Aboulafia
  • Ethel Cesarman

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms.

    Yoshio Koyanagi;Steven Miles;Ronald T. Mitsuyasu;Jean E. Merrill

  • Effect of Recombinant Human Granulocyte–Macrophage Colony-Stimulating Factor on Myelopoiesis in the Acquired Immunodeficiency Syndrome

    Jerome E. Groopman;Ronald T. Mitsuyasu;Michael J. DeLeo;Dagmar H. Oette

  • Decade-Long Safety and Function of Retroviral-Modified Chimeric Antigen Receptor T Cells

    John Scholler;Troy L. Brady;Gwendolyn Binder-Scholl;Wei-Ting Hwang

  • Infection with HIV is associated with elevated IL-6 levels and production.

    E C Breen;A R Rezai;K Nakajima;G N Beall

  • AIDS Kaposi sarcoma-derived cells produce and respond to interleukin 6.

    S A Miles;A R Rezai;J F Salazar-González;M Vander Meyden

  • Prolonged survival and tissue trafficking following adoptive transfer of CD4ζ gene-modified autologous CD4+ and CD8+ T cells in human immunodeficiency virus–infected subjects

    Ronald T. Mitsuyasu;Peter A. Anton;Steven G. Deeks;David T. Scadden

  • Interleukin-2 therapy in patients with HIV infection.

    D. Abrams;Y. Lévy;M. H. Losso;A. Babiker

  • Initial increase in blood CD4+ lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues

    R. Pat Bucy;Richard D. Hockett;Cynthia A. Derdeyn;Michael S. Saag

  • Recombinant alpha-2 interferon therapy for Kaposi's sarcoma associated with the acquired immunodeficiency syndrome

    Jerome E. Groopman;Michael S. Gottlieb;Jesse Goodman;Ronald T. Mitsuyasu

  • Anemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies

    Paul A. Volberding;Alexandra M. Levine;Douglas Dieterich;Donna Mildvan

  • Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

    Ronald T. Mitsuyasu;Thomas C. Merigan;Andrew D Carr;Jerome A. Zack

  • Treatment of donor bone marrow with monoclonal anti-T-cell antibody and complement for the prevention of graft-versus-host disease. A prospective, randomized, double-blind trial.

    R. T. Mitsuyasu;Richard E Champlin;R. P. Gale;W. G. Ho

  • A phase II randomized study of HIV-specific T-cell gene therapy in subjects with undetectable plasma viremia on combination antiretroviral therapy.

    Steven G. Deeks;Bridget Wagner;Peter A. Anton;Ronald T. Mitsuyasu

  • Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV-1-Infected Men

    Timothy Wilkin;Jeannette Y. Lee;Shelly Y. Lensing;Elizabeth A. Stier

  • Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma.

    Joseph A. Sparano;Jeannette Y. Lee;Lawrence D. Kaplan;Alexandra M. Levine

  • Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity.

    O Martínez-Maza;E Crabb;R T Mitsuyasu;J L Fahey

  • Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens.

    Hong Nerng Ho;Lance E. Hultin;Ronald T. Mitsuyasu;Jose L. Matud

  • Early effects of HIV on CD4 lymphocytes in vivo.

    J. V. Giorgi;J. L. Fahey;D. C. Smith;L. E. Hultin

  • Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients.

    Gayle Cocita Baldwin;Judith C. Gasson;Shirley G. Quan;Jacob Fleischmann

  • Treatment of Donor Bone Marrow with Monoclonal Anti-T-Cell Antibody and Complement for the Prevention of Graft-Versus-Host Disease

    Ronald T. Mitsuyasu;Richard E. Champlin;Robert Peter Gale;Winston G. Ho

  • after HIV antiretroviral therapy reflects redistribution from lymphoid tissues

    R. Pat Bucy;Richard D. Hockett;Cynthia A. Derdeyn;Michael S. Saag

Frequent Co-Authors

Jeannette Y. Lee
Jeannette Y. Lee University of Arkansas for Medical Sciences
Joseph A. Sparano
Joseph A. Sparano Albert Einstein College of Medicine
Lee Ratner
Lee Ratner Washington University in St. Louis
Richard F. Ambinder
Richard F. Ambinder Johns Hopkins University
John L. Fahey
John L. Fahey University of California, Los Angeles
Janis V. Giorgi
Janis V. Giorgi University of California, Los Angeles
Richard B. Pollard
Richard B. Pollard University of California, Davis
Ethel Cesarman
Ethel Cesarman Cornell University
Joel M. Palefsky
Joel M. Palefsky University of California, San Francisco
Steven G. Deeks
Steven G. Deeks University of California, San Francisco

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in immunology, exploring related healthcare degrees can open diverse career opportunities. Nursing programs, especially those focusing on advanced practice, offer accessible pathways. Prospective students may find easy nurse practitioner programs to get into that provide foundational skills relevant to immunology and patient care.

Mental health is another critical field intersecting with immunology, particularly for understanding psychoneuroimmunology. Specialized routes like top online pmhnp programs offer excellent clinical placement rates that can enhance hands-on experience and career readiness. For budget-conscious students, exploring cheapest online pmhnp programs ensures quality education without excessive financial burden.

Higher education like a Doctorate in Nursing Practice (DNP) can significantly boost earning potential and clinical expertise. To understand the financial benefits, reviewing the doctorate in nursing salary across different states provides valuable insights into career planning and long-term growth.

By combining immunology knowledge with nursing and mental health expertise, professionals can pursue rewarding careers in research, clinical practice, or healthcare leadership.

Best Scientists Citing Ronald T. Mitsuyasu

Trending Scientists

Recently Published Articles